Managers / Q3 2022 · view latest →
Iron Park Capital Partners, LP
CIK 0001845360 · C/O IRON PARK CAPITAL PARTNERS, 535 MADISON AVENUE, 31ST FLOOR, NEW YORK, NY, 10022 · 646-989-2500
Summary
Iron Park Capital Partners, LP reported $7M in U.S.-listed holdings across 2 positions for Q3 2022.
The portfolio is heavily concentrated: Medtech Acquisition alone accounts for 73.6% of reported value.
Compared with Q2 2022, the fund opened 0 new positions and exited 40.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Other · 73.6% · $5M
- Common Stock · 26.4% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| NORTH ATLANTIC ACQUISITN COR | SOLD OUT | −597.1K | 0 | −$6M | $0 |
| BROADSCALE ACQUISITION CORP | SOLD OUT | −550.0K | 0 | −$5M | $0 |
| CARTESIAN GROWTH CORP | SOLD OUT | −530.6K | 0 | −$5M | $0 |
| AVISTA PUB ACQUISITION CORP | SOLD OUT | −500.0K | 0 | −$5M | $0 |
| G SQUARED ASCEND I INC | SOLD OUT | −486.3K | 0 | −$5M | $0 |
| SOCIAL CAP SUVRETTA HLDS CRP | SOLD OUT | −451.1K | 0 | −$4M | $0 |
| INTERPRIVATE III FINANCIAL P | SOLD OUT | −411.6K | 0 | −$4M | $0 |
| PINE TECHNOLOGY ACQUISITN CO | SOLD OUT | −399.4K | 0 | −$4M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | MEDTECH ACQUISITION CORP | COM CL A | 73.55% | $5M | 550.0K |
| 2 | HORIZON GLOBAL CORP | COM | 26.45% | $2M | 1.60M |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2023 | $0 | 1 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $0 | 1 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $0 | 1 | May 2, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $620,914 | 1 | Jan 31, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $7M | 2 | Nov 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $93M | 42 | Aug 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $119M | 52 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $125M | 48 | Feb 10, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.